Navigation Links
Hyaluronic Acid Knee Procedures Grow 38% from Q3 2006 to Q3 2007
Date:11/26/2007

Orthopedic Surgeons and Rheumatologists Performing More Procedures

WALTHAM, Mass., Nov. 26 /PRNewswire/ -- Millennium Research Group's US Hyaluronic Acid (HA) Viscosupplementation Marketrack(TM) service, which captures data from both orthopedic surgeons and rheumatologists, shows that both groups provided more HA knee injections in Q3 2007 compared to Q3 2006. While treatments are growing in both groups, there are substantial differences in the products they use in these procedures.

In the survey sample, from Q3 2006 to Q3 2007, average quarterly orthopedic surgeon HA knee injection volumes jumped from 62 to nearly 85. Similarly, over the same time period, average quarterly HA knee injections for rheumatologists increased from 54 to over 75. Fueling this growth is the growing aging population, which is expanding the potential patient pool for HA viscosupplementation each year. In addition, expanding patient awareness of the benefits of HA viscosupplementation injections is also increasing the number of patients seeking and ultimately receiving treatment.

"While both groups' injection numbers are rising, they are using different products," says Kevin Flewwelling, Senior Analyst at MRG. "It turns out that in Q307, orthopedic surgeons mostly used Genzyme's Synvisc, which represented nearly 39% of the total injections administered by orthopedic surgeons. Rheumatologists, on the other hand, tended to use sanofi aventis' Hyalgan most often, which accounted for almost 36% of the total injections administered by this group."

When both groups were asked to rank the most important reasons for prescribing HA viscosupplementation, orthopedic surgeons ranked product efficacy as their number one reason, while rheumatologists reported long-term pain relief as their first priority.

About Hyaluronic Acid Viscosupplementation Marketrack(TM)

HA Viscosupplementation Marketrack(TM) gathers data from 260 orthopedic surgeons, rheumatologis
'/>"/>

SOURCE Millennium Research Group
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
2. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... 4 NeoStem, Inc.,(NYSE ...sease collection,processing and long-term storag...day announced that it has reached a major mileston...f the first ever collection center for collection ...ure medical need in New York,City and has chosen ...
(Date:12/4/2008)...rance, Dec. 4 A 60-year-...become the first person in France,to be treated u...ystems,(NYSE: VAR ) for fast and precise forms ...of his treatments at the CRLC Val D,Aurelle - Paul...al times faster than conventional IMRT,treatments...
(Date:12/4/2008)...Introduces New Trade Name Onrigin(TM) for Laromust...e-FirstCall/ -- VION PHARMACEUTICALS, INC. (OTC B...ents related to events in connection with the 50th...the Moscone Center in San Francisco from December ... , , The Company announced that it would ...
(Date:12/4/2008)... 4 Delcath Systems, Inc....ewis, M.D., Ph.D., has stepped down from his posit...er 2, 2008. Dr. Lewis advised the Company that hi...of additional commitments to new leadership positi...i-bin/prnh/20081118/NY46990LOGO ) , , Dr. H...
Breaking Biology Technology:NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 4Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors 2
... , , Key words: serotonin &bul...LEADseeker • SPA Imaging Beads , ,..., 5-HT) is a regulator of neural transmission whic...tonin receptors. <P ,>The serotonin 5-HT 2C ...hat belongs to the rhodopsin-like seven transmembr...
... , , Key words: NK2 • GP...eker • SPA Imaging Beads , , ...mily of small neuropeptides. Members of this famil... (NKA), neurokinin B (NKB), and the recently disco...ributed throughout the central and peripheral nerv...
... , , Key words: EFC chemilumin... , Competitive pressure is forcing or...ughput. Yet accuracy and sensitivity remain vital ...luminescence assays. LEADseeker™ Multimodali...nds by combining excellent detection with the abil...
... , The Ettan™ DIGE Imager (F...ations in the life sciences. In particular, it has...2-D DIGE gels. By combining high resolution with p...ces accurate multichannel images of your Cy™... been designed to image a wide range of other fluo...
Other Biology Technology:The development of a serotonin 5-HT2C receptor-binding assay using the LEADseeker Multimodality Imaging System 2The development of a serotonin 5-HT2C receptor-binding assay using the LEADseeker Multimodality Imaging System 3The development of a serotonin 5-HT2C receptor-binding assay using the LEADseeker Multimodality Imaging System 4Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System 2Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System 3Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System 4Use of the HitHunter EFC Chemiluminescent Detection Kits with LEADseeker Multimodality Imaging System 2Use of the HitHunter EFC Chemiluminescent Detection Kits with LEADseeker Multimodality Imaging System 3Use of the HitHunter EFC Chemiluminescent Detection Kits with LEADseeker Multimodality Imaging System 4Ettan DIGE Imager 2Ettan DIGE Imager 3
(Date:12/3/2008)...E"...Though they may not help improve a person,s g...golfers think about the local country club in the ...i study. , "There are more than 17,000 golf cour...cent of that land is not used for playing," said R...e MU College of Arts and Science. "These managed g...
(Date:12/3/2008)...rus to insert a corrective gene into mouse blood c...ospital have alleviated sickle cell disease pathol...the treated mice showed essentially no difference ...that applying the gene therapy to humans presents ... the new therapy will become an important treatmen...
(Date:12/3/2008)...nding success of the first tandem mission between ...o satellites together again to help improve our un...n spacecraft, and Envisat, the largest environment...ture Radar (SAR) instruments that provide high res...ining two or more SAR images of the same site, sli...
(Date:12/3/2008)...LE, Mass. Natural changes in voltage that occur a... powerful controlling factor in the process by whi...search published by Tufts University scientists. ...essor of Biology Michael Levin, and Chair of Biome...uthor) published their paper "Membrane Potential ...
Breaking Biology News(10 mins):Golf course: Playing fields, wildlife sanctuaries or both 2Gene therapy corrects sickle cell disease in laboratory study 2Gene therapy corrects sickle cell disease in laboratory study 3ESA satellites flying in formation 2New 'control knobs' for stem cells identified 2Gold Rush 21 The Monks go Gold and Platinum 25983 1Excercise May Help Prevent Age Related Memory Loss 25982 1Excercise May Help Prevent Age Related Memory Loss 25982 2Nearly half of US adults will develop painful knee osteoarthritis by age 85 3A study 25978 1Nearly half of US adults will develop painful knee osteoarthritis by age 85 3A study 25978 2Healthy Minds Across America features 48 public forums on mental health research Sept 14 4676 1Healthy Minds Across America features 48 public forums on mental health research Sept 14 4676 2Healthy Minds Across America features 48 public forums on mental health research Sept 14 4676 3
... ?a siesta after a hearty lunch is natural, new re... Manchester have for the first time uncovered how ... turned off after we eat. , The findings ?publish...e implications for treating obesity and eating dis...sness. , "It has been known for a while that peop...
...ns in the brains of individuals addicted to cocain...echanisms that may one day lead to new treatment o... in the current issue of Molecular Psychiatry, rel...ts of 50 proteins and point to profound changes in...said Scott E. Hemby, Ph.D., of Wake Forest Univers...
...f developing cancer as they get older may be expla...tists have discovered that a naturally produced pr...etermine how long we live. , The findings ?publis...up a new avenue of inquiry into ageing as a risk f...eins that prevent cancer in humans by ensuring tha...
...al,s immune response to the 1918 influenza virus p...ederally supported scientists in an article appear...these insights, they found that the 1918 virus tri...ibute to the lethality of the virus. Furthermore,...of all eight of the 1918 flu virus genes interacti...
Other Biology News:Why we could all do with a siesta 2High-tech research shows cocaine changes proteins and brain function 2Worm links cancer risk to ageing 2Mouse study reveals new clues about virulence of 1918 influenza virus 2Mouse study reveals new clues about virulence of 1918 influenza virus 3
Phospho-C/EBPbeta (Thr235) Antibody
Anti-BAR Immunogen: Peptide of aa 3-21 from human Bar Available Date: 38226
TUP1 Market Segment: Molecular Biology
In plasmid or lambda vector. Please inquire for more details!
Biology Products: